The Bharat Biotech (Covaxin) vaccine he received on November 20 has a two dose schedule at a 28-day interval. He only received the first dose. Phase 3 trials (28k people) have just begun and we must atleast wait atleast for an interim analysis in those who received both doses. https://twitter.com/ANI/status/1335096256306106368

+ If he was a part of the clinical trial proper, he would be randomized into the vaccine arm or the placebo arm. There's a possibility he got the placebo but the point is that even if he got the vaccine, it is only 15 days and he has only received one dose.(Article dated 26/11)

+ Even in Pfizer & Moderna's phase 3 trials, among those who tested +ve at the time of interim analysis, 5-8% had received the vaccine. The rest were those who received a placebo. Hence the vaccine efficacy of 92-95%.

Perspective vs spreading panic, please.